Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment.

about

Current treatment of central retinal artery occlusion: a national survey.Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.

P2860

Q47194291-9E65A74C-53E5-436E-828A-6B75E9A40A3C Q55513382-1E884D9C-60F7-49DA-92B1-782543F863F2

P2860

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment.

Item

http://www.wikidata.org/entity/Q40562643

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Predictors of prognosis and tr ...... is vs. conservative treatment.

@en

type

Item

label

Predictors of prognosis and tr ...... is vs. conservative treatment.

@en

prefLabel

Predictors of prognosis and tr ...... is vs. conservative treatment.

@en

P1476

Predictors of prognosis and tr ...... is vs. conservative treatment.

@en

P2093

Bernd Junker

http://www.w3.org/2001/XMLSchema#string

Claudia Schmoor

http://www.w3.org/2001/XMLSchema#string

EAGLE Study Group

http://www.w3.org/2001/XMLSchema#string

Josep Callizo

http://www.w3.org/2001/XMLSchema#string

Martin Schumacher

http://www.w3.org/2001/XMLSchema#string

Nicolas Feltgen

http://www.w3.org/2001/XMLSchema#string

Stefanie Pantenburg

http://www.w3.org/2001/XMLSchema#string

P2860

Preconditioning for traumatic brain injury

Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion

Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1

Tissue plasminogen activator for acute ischemic stroke

Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations.

Central retinal artery occlusion and retinal tolerance time.

Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Poststroke outcomes vary by pathogenic stroke subtype in the Atherosclerosis Risk in Communities Study.

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

State-of-the-art reperfusion strategies for acute ischemic stroke.

P2888

s00234-015-1588-3

P304

1055-1062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00234-015-1588-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amelie Pielen

P577

2015-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281637104

http://www.w3.org/2001/XMLSchema#string

P698

26349479

http://www.w3.org/2001/XMLSchema#string

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment.

about

P2860

P2860

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698